Hormonal Contraceptive Market Size, Trends, Analysis, and Outlook By Hormone, Combination Hormonal Contraceptives, Progestin Only), By Method (Pill, Intrauterine Device (IUD), Injectable, Vaginal Ring, Implant, Patch), by Region, Country, Segment, and Companies, 2024-2030
The global Hormonal Contraceptive market size is poised to register 5.09% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hormonal Contraceptive market across By Hormone, Combination Hormonal Contraceptives, Progestin Only), By Method (Pill, Intrauterine Device (IUD), Injectable, Vaginal Ring, Implant, Patch).
The hormonal contraceptive market is experiencing steady growth driven by increasing awareness about family planning, rising prevalence of unintended pregnancies, and advancements in contraceptive formulations and delivery methods. Hormonal contraceptives, such as birth control pills, patches, injections, and vaginal rings, contain synthetic hormones, such as estrogen and progestin, which work by suppressing ovulation, thickening cervical mucus, and thinning the uterine lining to prevent pregnancy. Factors such as the growing acceptance of hormonal contraception, expanding contraceptive coverage and accessibility, and rising demand for long-acting reversible contraceptives (LARCs) are driving market expansion. Additionally, advancements in contraceptive technologies, increasing availability of over-the-counter (OTC) contraceptives, and expanding initiatives to promote family planning and reproductive health are further fueling market growth. Moreover, expanding applications of hormonal contraceptives for menstrual regulation, acne treatment, and hormone replacement therapy (HRT), and rising adoption of novel delivery methods, such as transdermal patches and contraceptive implants, are expected to drive market growth in the foreseeable future. Furthermore, collaborations between contraceptive manufacturers, healthcare providers, and advocacy organizations, as well as efforts to develop user-friendly and culturally sensitive contraceptive products, improve contraceptive access and affordability, and address barriers to contraceptive use, are likely to accelerate market expansion.
Hormonal Contraceptive Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Hormonal Contraceptive market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Hormonal Contraceptive survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Hormonal Contraceptive industry.
Key market trends defining the global Hormonal Contraceptive demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Hormonal Contraceptive Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Hormonal Contraceptive industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Hormonal Contraceptive companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Hormonal Contraceptive industry
Leading Hormonal Contraceptive companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Hormonal Contraceptive companies.
Hormonal Contraceptive Market Study- Strategic Analysis Review
The Hormonal Contraceptive market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Hormonal Contraceptive industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Hormonal Contraceptive Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Hormonal Contraceptive Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Hormonal Contraceptive market segments. Similarly, Strong end-user demand is encouraging Canadian Hormonal Contraceptive companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Hormonal Contraceptive market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Hormonal Contraceptive Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Hormonal Contraceptive industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Hormonal Contraceptive market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Hormonal Contraceptive Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Hormonal Contraceptive in Asia Pacific. In particular, China, India, and South East Asian Hormonal Contraceptive markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Hormonal Contraceptive Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Hormonal Contraceptive Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Hormonal Contraceptive market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Hormonal Contraceptive.
Hormonal Contraceptive Market Company Profiles
The global Hormonal Contraceptive market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbvie Inc, Afaxys Inc, Agile Therapeutics, Bayer AG, Janssen Pharmaceuticals Inc, Lupin Pharmaceuticals Inc, Organon Group of Companies, Pfizer, Pregna International Ltd, Teva Pharmaceuticals Industries Ltd
Recent Hormonal Contraceptive Market Developments
The global Hormonal Contraceptive market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Hormonal Contraceptive Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Hormone
Combination Hormonal Contraceptives
Progestin Only
By Method
Pill
Intrauterine Device (IUD)
Injectable
Vaginal Ring
Implant
Patch
Geographical Segmentation:
Abbvie Inc
Afaxys Inc
Agile Therapeutics
Bayer AG
Janssen Pharmaceuticals Inc
Lupin Pharmaceuticals Inc
Organon Group of Companies
Pfizer
Pregna International Ltd
Teva Pharmaceuticals Industries Ltd
Formats Available: Excel, PDF, and PPT
The hormonal contraceptive market is experiencing steady growth driven by increasing awareness about family planning, rising prevalence of unintended pregnancies, and advancements in contraceptive formulations and delivery methods. Hormonal contraceptives, such as birth control pills, patches, injections, and vaginal rings, contain synthetic hormones, such as estrogen and progestin, which work by suppressing ovulation, thickening cervical mucus, and thinning the uterine lining to prevent pregnancy. Factors such as the growing acceptance of hormonal contraception, expanding contraceptive coverage and accessibility, and rising demand for long-acting reversible contraceptives (LARCs) are driving market expansion. Additionally, advancements in contraceptive technologies, increasing availability of over-the-counter (OTC) contraceptives, and expanding initiatives to promote family planning and reproductive health are further fueling market growth. Moreover, expanding applications of hormonal contraceptives for menstrual regulation, acne treatment, and hormone replacement therapy (HRT), and rising adoption of novel delivery methods, such as transdermal patches and contraceptive implants, are expected to drive market growth in the foreseeable future. Furthermore, collaborations between contraceptive manufacturers, healthcare providers, and advocacy organizations, as well as efforts to develop user-friendly and culturally sensitive contraceptive products, improve contraceptive access and affordability, and address barriers to contraceptive use, are likely to accelerate market expansion.
Hormonal Contraceptive Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Hormonal Contraceptive market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Hormonal Contraceptive survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Hormonal Contraceptive industry.
Key market trends defining the global Hormonal Contraceptive demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Hormonal Contraceptive Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Hormonal Contraceptive industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Hormonal Contraceptive companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Hormonal Contraceptive industry
Leading Hormonal Contraceptive companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Hormonal Contraceptive companies.
Hormonal Contraceptive Market Study- Strategic Analysis Review
The Hormonal Contraceptive market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Hormonal Contraceptive industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Hormonal Contraceptive Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Hormonal Contraceptive Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Hormonal Contraceptive market segments. Similarly, Strong end-user demand is encouraging Canadian Hormonal Contraceptive companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Hormonal Contraceptive market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Hormonal Contraceptive Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Hormonal Contraceptive industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Hormonal Contraceptive market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Hormonal Contraceptive Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Hormonal Contraceptive in Asia Pacific. In particular, China, India, and South East Asian Hormonal Contraceptive markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Hormonal Contraceptive Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Hormonal Contraceptive Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Hormonal Contraceptive market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Hormonal Contraceptive.
Hormonal Contraceptive Market Company Profiles
The global Hormonal Contraceptive market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbvie Inc, Afaxys Inc, Agile Therapeutics, Bayer AG, Janssen Pharmaceuticals Inc, Lupin Pharmaceuticals Inc, Organon Group of Companies, Pfizer, Pregna International Ltd, Teva Pharmaceuticals Industries Ltd
Recent Hormonal Contraceptive Market Developments
The global Hormonal Contraceptive market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Hormonal Contraceptive Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Hormone
Combination Hormonal Contraceptives
Progestin Only
By Method
Pill
Intrauterine Device (IUD)
Injectable
Vaginal Ring
Implant
Patch
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbvie Inc
Afaxys Inc
Agile Therapeutics
Bayer AG
Janssen Pharmaceuticals Inc
Lupin Pharmaceuticals Inc
Organon Group of Companies
Pfizer
Pregna International Ltd
Teva Pharmaceuticals Industries Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Hormonal Contraceptive Market Overview and Key Findings, 2024
1.2 Hormonal Contraceptive Market Size and Growth Outlook, 2021- 2030
1.3 Hormonal Contraceptive Market Growth Opportunities to 2030
1.4 Key Hormonal Contraceptive Market Trends and Challenges
1.4.1 Hormonal Contraceptive Market Drivers and Trends
1.4.2 Hormonal Contraceptive Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Hormonal Contraceptive Companies
2. HORMONAL CONTRACEPTIVE MARKET SIZE OUTLOOK TO 2030
2.1 Hormonal Contraceptive Market Size Outlook, USD Million, 2021- 2030
2.2 Hormonal Contraceptive Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. HORMONAL CONTRACEPTIVE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. HORMONAL CONTRACEPTIVE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Hormone
Combination Hormonal Contraceptives
Progestin Only
By Method
Pill
Intrauterine Device (IUD)
Injectable
Vaginal Ring
Implant
Patch
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Hormonal Contraceptive Market, 2025
5.2 Asia Pacific Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Hormonal Contraceptive Market, 2025
5.5 Europe Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.6 Europe Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Hormonal Contraceptive Market, 2025
5.8 North America Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.9 North America Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Hormonal Contraceptive Market, 2025
5.11 South America Pacific Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.12 South America Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Hormonal Contraceptive Market, 2025
5.14 Middle East Africa Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Hormonal Contraceptive Market Size Outlook and Revenue Growth Forecasts
6.2 US Hormonal Contraceptive Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Hormonal Contraceptive Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Hormonal Contraceptive Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Hormonal Contraceptive Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Hormonal Contraceptive Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Hormonal Contraceptive Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Hormonal Contraceptive Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Hormonal Contraceptive Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Hormonal Contraceptive Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Hormonal Contraceptive Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Hormonal Contraceptive Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Hormonal Contraceptive Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Hormonal Contraceptive Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Hormonal Contraceptive Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Hormonal Contraceptive Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Hormonal Contraceptive Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Hormonal Contraceptive Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Hormonal Contraceptive Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Hormonal Contraceptive Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Hormonal Contraceptive Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Hormonal Contraceptive Industry Drivers and Opportunities
7. HORMONAL CONTRACEPTIVE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. HORMONAL CONTRACEPTIVE COMPANY PROFILES
8.1 Profiles of Leading Hormonal Contraceptive Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbvie Inc
Afaxys Inc
Agile Therapeutics
Bayer AG
Janssen Pharmaceuticals Inc
Lupin Pharmaceuticals Inc
Organon Group of Companies
Pfizer
Pregna International Ltd
Teva Pharmaceuticals Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Hormonal Contraceptive Market Overview and Key Findings, 2024
1.2 Hormonal Contraceptive Market Size and Growth Outlook, 2021- 2030
1.3 Hormonal Contraceptive Market Growth Opportunities to 2030
1.4 Key Hormonal Contraceptive Market Trends and Challenges
1.4.1 Hormonal Contraceptive Market Drivers and Trends
1.4.2 Hormonal Contraceptive Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Hormonal Contraceptive Companies
2. HORMONAL CONTRACEPTIVE MARKET SIZE OUTLOOK TO 2030
2.1 Hormonal Contraceptive Market Size Outlook, USD Million, 2021- 2030
2.2 Hormonal Contraceptive Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. HORMONAL CONTRACEPTIVE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. HORMONAL CONTRACEPTIVE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Hormone
Combination Hormonal Contraceptives
Progestin Only
By Method
Pill
Intrauterine Device (IUD)
Injectable
Vaginal Ring
Implant
Patch
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Hormonal Contraceptive Market, 2025
5.2 Asia Pacific Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Hormonal Contraceptive Market, 2025
5.5 Europe Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.6 Europe Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Hormonal Contraceptive Market, 2025
5.8 North America Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.9 North America Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Hormonal Contraceptive Market, 2025
5.11 South America Pacific Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.12 South America Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Hormonal Contraceptive Market, 2025
5.14 Middle East Africa Hormonal Contraceptive Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Hormonal Contraceptive Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Hormonal Contraceptive Market Size Outlook and Revenue Growth Forecasts
6.2 US Hormonal Contraceptive Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Hormonal Contraceptive Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Hormonal Contraceptive Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Hormonal Contraceptive Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Hormonal Contraceptive Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Hormonal Contraceptive Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Hormonal Contraceptive Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Hormonal Contraceptive Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Hormonal Contraceptive Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Hormonal Contraceptive Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Hormonal Contraceptive Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Hormonal Contraceptive Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Hormonal Contraceptive Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Hormonal Contraceptive Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Hormonal Contraceptive Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Hormonal Contraceptive Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Hormonal Contraceptive Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Hormonal Contraceptive Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Hormonal Contraceptive Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Hormonal Contraceptive Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Hormonal Contraceptive Industry Drivers and Opportunities
7. HORMONAL CONTRACEPTIVE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. HORMONAL CONTRACEPTIVE COMPANY PROFILES
8.1 Profiles of Leading Hormonal Contraceptive Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbvie Inc
Afaxys Inc
Agile Therapeutics
Bayer AG
Janssen Pharmaceuticals Inc
Lupin Pharmaceuticals Inc
Organon Group of Companies
Pfizer
Pregna International Ltd
Teva Pharmaceuticals Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
